Treatment of Arachnoid Cyst With Spontaneous Hemorrhage With Atorvastatin

Bei Liu1, Chao Wang1, Yan Qu1

  • 1Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.

Frontiers in Pharmacology
|December 12, 2019
PubMed

Insights

Atorvastatin effectively resolved subdural hematoma in a pediatric patient with recurrent middle fossa arachnoid cyst (MFAC) rupture, even after failed surgeries. This finding suggests atorvastatin as a safe and promising treatment option for similar complex neurological cases.

Area of Science:

  • Neurology
  • Pediatric Neurosurgery
  • Pharmacology

Background:

  • Middle fossa arachnoid cysts (MFACs) are common pediatric neurological conditions that can lead to complications like intracystic hemorrhage and subdural hematoma.
  • Surgical intervention for MFACs with subdural hematoma in children has a high recurrence rate, necessitating alternative treatment strategies.

Observation:

  • A 7-year-old child presented with recurrent subdural hematoma resulting from a ruptured MFAC, with previous surgical treatments proving ineffective.
  • The patient was treated with atorvastatin monotherapy (5 mg daily, then 10 mg daily for 7 weeks).

Findings:

  • Atorvastatin treatment led to complete resolution of the subdural hematoma within three months.
  • The pediatric patient experienced significant neurological function recovery following atorvastatin therapy.

Implications:

  • This case report highlights atorvastatin as a safe and effective therapeutic option for pediatric patients with subdural hematoma secondary to MFAC rupture, particularly when surgery fails.
  • Atorvastatin may promote the absorption of subdural hematomas, offering a non-surgical management approach for complex pediatric neurological cases.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
285
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
221
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
240